Nanotheranostics for personalized medicine
Explore this paper's citation graph
Summary
Current nanotechnology-based theranostics systems engineered for PM applications are not yet sufficient, and the authors dissect the requirements for successful nanotheranostics-based PM.
- Type
- review
- Published
- 2013-04-01
- Cited by
- 152
- References
- 92
- Access
- Open access
- OpenAlex
- https://openalex.org/W1985839726
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20879850
Keywords
Personalized medicine, Medicine, Precision medicine, Bioinformatics, Biology
References
- Monoclonal antibody therapy of cancer.
- Molecular classification of cutaneous malignant melanoma by gene expression profiling
- Pericellular cathepsin B and malignant progression
- Personalized medicine: part 1: evolution and development into theranostics.
- Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
- Simultaneous Analysis of Multiple Data Types in Pharmacogenomic Studies Using Weighted Sparse Canonical Correlation Analysis
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
- Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
- Relaxometry and magnetometry of the MR contrast agent MION‐46L
- Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery
- Moving theranostics trom bench to bedside in an interdisciplinary research team.
- Nanotheranostics for personalized medicine.
- Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials
- Electrochemical Immunosensors for Detection of Cancer Protein Biomarkers
- Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles
- One Year after a Successful Start of Theranostics
- Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.
- Potent antibody drug conjugates for cancer therapy.
- Nanotheranostics – a review of recent publications
- High-sensitivity nanosensors for biomarker detection
Cited by
- Multimodal Microscopy Distinguishes Extracellular Aggregation and Cellular Uptake of Single-Walled Carbon Nanohorns.
- What's in a word? The person of personalized (nano)medicine.
- Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles
- Applications of nanoparticles for diagnosis and therapy of cancer
- A biological perspective toward the interaction of theranostic nanoparticles with the bloodstream – what needs to be considered?
- Core–shell monodisperse spherical mSiO2/Gd2O3:Eu3+@mSiO2 particles as potential multifunctional theranostic agents
- Theranostic nanoparticles for future personalized medicine.
- Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
- Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
- Nanotheragnostic Applications for Ischemic and Hemorrhagic Strokes: Improved Delivery for a Better Prognosis
- Effects of graphene on seed germination and seedling growth
- Fundamentals and Application of Magnetic Particles in Cell Isolation and Enrichment
- Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: the jack-of-all-trades in cancer nanotheranostics?
- An activatable prodrug for the treatment of metastatic tumors.
- Tracing nanoparticles and photosensitizing molecules at transmission electron microscopy by diaminobenzidine photo-oxidation.
- Probing the relevance of 3D cancer models in nanomedicine research.
- Techniques for physicochemical characterization of nanomaterials
- Theranostics: A treasured tailor for tomorrow
- Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
- Graphene oxide modulates root growth of Brassica napus L. and regulates ABA and IAA concentration.
Related papers
- The future of precision medicine: towards a more predictive personalized medicine.
- TRANSFORMING HEALTHCARE WITH PRECISION MEDICINE: UNVEILING THE FUTURE OF PERSONALIZED TREATMENT
- Detecting Personalized Determinants During Drug Treatment from Omics Big Data.
- Critical Care and Personalized or Precision Medicine: Who needs whom?
- Genomic medicine on the frontier of precision medicine
- Precision Medicine: Tailoring Treatment to the Individual's Genomic Profile
- Prediction and Recommendation of Precision Medicine for Cancer using Machine Learning Techniques
- Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment